Made entirely from polypropylene (PP), all the PCR range containers are mono-material which facilitates ongoing recycling and circularity
Berry supplies PCR containers to help meet sustainability goals. (Credit: Berry Global Inc.)
US-based plastic packaging products maker Berry Global has provided containers made with post-consumer recycled plastic (PCR) to Scandinavia’s de-icing company Everbrand.
According to Berry Global, the containers will support the brands in their sustainability strategy.
Everbrand recently shifted to the packaging solution for its IS-FRITT range of de-icing products.
Everbrand CEO Alexander Axelsson said: “An obvious next step in our sustainability strategy was to change the material composition of the containers we use for IS-FRITT.
“Our goal was to reduce the use of virgin plastic for packaging and to use recycled material instead while also ensuring that our containers can be recycled again after they have been used.”
The solution from the company’s long-term packaging partner Berry was to retain the existing SuperLift container but to now feature 50% PCR in its manufacture.
Additionally, the container’s colour was modified from white to a shade of grey to further enhance its individuality.
The Berry PCR line includes SuperLift, which offers a wide selection of containers in several sizes and shapes with up to 50% PCR material as standard.
The range retains the advantages like lightweight, easy handling, and consumer convenience.
Made entirely from polypropylene (PP), all the PCR range containers are mono-material which facilitates ongoing recycling and circularity, Berry Global said.
Axelsson added: “We have always been very satisfied with the SuperLift container and were quite relieved that Berry was able to deliver it with recycled plastic content.
“It fully meets our other demands as well: it is eye-catching, has high quality, is sturdy and stackable.”
Last week, the packaging firm unveiled a child-resistant closure that has been developed to improve medication adherence by integrating digital technology.
Berry said that the new patent-pending 38mm Berry Digi-Cap digital child-resistant closure is fit for clinical studies, the development of drugs, and academic research.